Pharma has a hiding place during recession

As pharma companies begin reporting earnings next week, investors could be forgiven for paying more attention…

Long Covid is an elusive target for Big Pharma

This is the second column in the three-part Heard on the Street series on Long Covid.…

Big Pharma will not grant bail to battered biotech

Share Market It may have been in a recession, but the Biotechnology Index has fallen off…

Bristol-Myers to buy Turning Point Therapeutics for $4.1 billion

Bristol-Myers Squibb Company said it has agreed to buy clinical-stage precision-oncology company Turning Point Therapeutics Deepening…